logo-loader
viewCB2 Insights

Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from former Johnson & Johnson executive

Also on the move were Cannvas MedTech, Harvest Health & Recreation, Canopy Growth and Choom

cannabis
CB2 Insights rose as it named former J&J executive.Peter Cummins to its board

Cannabis stocks inched higher across all three indices on Wednesday.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, rose 1.2% to hit 213.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF added 1.2% to C$16.33, while the OTCQX Cannabis Index was up 0.9% to 712.7 points.

Buds

CB2 Insights (CSE:CBII) (OTCQB:CBIIF), the medical cannabis analytics company, got a bump in price after adding new talent to its board of directors in the form of retired Johnson & Johnson (NYSE:JNJ) executive Peter Cummins.

Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles, overseeing research and development, external innovation, regulatory affairs and other areas over the course of his career.

Shares of CB2 rose 7.9% on Wednesday to C$0.21.

Also rising was Cannvas MedTech Inc (CSE:MTEC) (OTCMKTS:CANVF), which reported a share exchange deal with 1216165 BC Ltd, better known as True Focus International, to get the exclusive rights to market its suite of products, and at the same time announced plans to change the company's name to Eurolife Brands Inc.

The Vancouver digital cannabis education and analytics company will receive access to True Focus International’s intellectual property portfolio across South America and parts of Europe for 10 years.

Cannvas shares were up 2.2% at C$0.24 during morning trading in Canada.

Harvest Health & Recreation Inc (CSE:HARV) shares also jumped 5.3% to C$7.18 after announcing it had secured a US$225 million loan from Torian Capital Partners to help fund its expansion plans across key markets in the US.

Duds

Not all cannabis stocks were in the green on Wednesday. Canopy Growth Corp (TSE:WEED) (NYSE:CGC) lost nearly 0.5% at C$43.67 ahead of announcing its 1Q 2020 financial results, the last quarter under founder and former CEO Bruce Linton’s leadership.

Also down was Canadian retailer Choom (CSE:CHOO) (OTCMKTS:CHOOF), which announced a change in leadership with incoming president Corey Gillon taking the reins of the cannabis company.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: CB2 Insights

Price: 0.085 CAD

CSE:CBII
Market: CSE
Market Cap: $6.7 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of CB2 Insights named herein, including the promotion by the Company of CB2 Insights in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

1 month ago

2 min read